Outcomes of acute phase cognitive therapy in outpatients with anxious versus nonanxious depression (Q30514247)

11 August 2017

Outcomes of acute phase cognitive therapy in outpatients with anxious versus nonanxious depression (English)

1 reference

11 August 2017

3

Michael E Thase

1 reference

11 August 2017

1

Jasper A J Smits

1 reference

11 August 2017

Abu Minhajuddin

2

1 reference

PMC publication ID

3362240

11 August 2017

Robin B Jarrett

series ordinal

4

1 reference

11 August 2017

3 March 2012

1 reference

Psychotherapy and Psychosomatics

11 August 2017

1 reference

11 August 2017

81

1 reference

11 August 2017

3

1 reference

11 August 2017

153-160

1 reference

Prevalence and treatment outcome in anxious versus nonanxious depression: results from the German Algorithm Project

11 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3362240

Comparative efficacy and durability of continuation phase cognitive therapy for preventing recurrent depression: design of a double-blinded, fluoxetine- and pill placebo-controlled, randomized trial with 2-year follow-up

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3362240

New modalities of assessment and treatment planning in depression: the sequential approach

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3362240

Cognitive therapy for depressed adults with comorbid social phobia

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3362240

How much cognitive therapy, for which patients, will prevent depressive relapse?

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3362240

Defining anxious depression: going beyond comorbidity

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3362240

A rating scale for depression

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3362240

An Inventory for Measuring Depression

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3362240

Preventing recurrent depression using cognitive therapy with and without a continuation phase: a randomized clinical trial

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3362240

A functional anlysis of depression

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3362240

Achieving remission with venlafaxine and fluoxetine in major depression: its relationship to anxiety symptoms

20 June 2018

1 reference

Difference in treatment outcome in outpatients with anxious versus nonanxious depression: a STAR*D report.

21 January 2018

1 reference

Psychic and somatic anxiety symptoms as predictors of response to fluoxetine in major depressive disorder

21 January 2018

1 reference

Clinical correlates and symptom patterns of anxious depression among patients with major depressive disorder in STAR*D.

21 January 2018

1 reference

What clinical and symptom features and comorbid disorders characterize outpatients with anxious major depressive disorder: a replication and extension

21 January 2018

1 reference

Subtyping major depressive disorder

21 January 2018

1 reference

Mindfulness-based cognitive therapy to prevent relapse in recurrent depression.

21 January 2018

1 reference

Are treatment preferences relevant in response to serotonergic antidepressants and cognitive-behavioral therapy in depressed primary care patients? Results from a randomized controlled trial including a patients' choice arm.

21 January 2018

1 reference

Symptomatic and syndromal anxiety in chronic forms of major depression: effect of nefazodone, cognitive behavioral analysis system of psychotherapy, and their combination

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3362240

The Cognitive Therapy Scale: psychometric properties

26 November 2018

1 reference

12 December 2020

The inventory for depressive symptomatology (IDS): Preliminary findings

1 reference

12 December 2020

Relapse after cognitive behavior therapy of depression: potential implications for longer courses of treatment

1 reference

12 December 2020

Anxious and nonanxious depression

1 reference

12 December 2020

Abnormal electroencephalographic sleep profiles in major depression: association with response to cognitive behavior therapy

1 reference

12 December 2020

Anxious depression in elderly patients. Response to antidepressant treatment

1 reference

12 December 2020

Mediation of changes in anxiety and depression during treatment of social phobia

1 reference

12 December 2020

Identifiers

DOI

10.1159/000334909

1 reference

11 August 2017

1 reference

PMC publication ID

3362240

11 August 2017

PubMed publication ID

22398963

1 reference

PMC publication ID

3362240